Loading... Please wait...
App Store Download on the App Store Google Play GET IT ON Google Play

VolitionRx Limited (VNRX) Stock Price, News & Analysis

Currency in USD Disclaimer
Add to Alerts
Add to Watchlist
$0.62 -$0.03 (-3.88%)
$0.61
$0.65
$0.55
$1.55
Track all markets on TradingView

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -21.39
  • Piotroski Score 3.00
  • Grade Buy

Company brief: VolitionRx Limited (VNRX)

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.

Price Target and Rating

  • $0.00
  • $0.00
  • $0.00
  • N/A
  • Sell
  • N/A
  • N/A

Profitability

  • -$0.45
  • -1.51
  • -1.51
  • -1.51
  • $-35,319,078

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Latest News of VNRX

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In

or
Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Sign Up With Email Address
or
Continue with Google Continue with Apple

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.